logo
Public Health: Confirmed case of tuberculosis at Highline College

Public Health: Confirmed case of tuberculosis at Highline College

Yahoo30-05-2025

A member of Highline College has been diagnosed with an active tuberculosis (TB) infection.
Public Health – Seattle & King County says it is working with the college to define the extent of exposure cases.
The health agency has identified 10 people who should be screened based on possible exposures from January 2025 to March 2025.
They say individuals believed to have been exposed during this period will be contacted by Public Health.
TB is caused by an airborne bacterial infection passed from person to person primarily through prolonged contact while indoors.
The infection affects many body parts, including the lungs, lymph nodes, bones, and joints.
Most cases of TB can be treated with antibiotics, and treatment usually takes six to nine months.
Public Health says the person at Highline College who has active TB disease is receiving treatment and is currently not a risk for infecting others.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Secretary Of HHS Kennedy Fires Entire CDC's Vaccine Advisory Committee
Secretary Of HHS Kennedy Fires Entire CDC's Vaccine Advisory Committee

Forbes

time8 hours ago

  • Forbes

Secretary Of HHS Kennedy Fires Entire CDC's Vaccine Advisory Committee

Secretary of Health and Human Services, Robert F. Kennedy Jr., is making good on his promise to radically reshape the vaccine policy landscape as he ousts the entire Centers for Disease Control and Prevention Advisory Committee on Immunization Practices. In a press release issued by the Department of HHS on June 9th, Kennedy says he's doing this in order to restore the public's trust in vaccine science in America. It's unknown who Kennedy will hire to replace committee members, but it's possible they may share his skeptical views of vaccines. In turn, this could have the effect of increasing the public's vaccine hesitancy. ACIP advises the director of the CDC on which vaccines approved by the Food and Drug Administration should be used; for example, recommending which groups of people ought to be vaccinated, at what doses and when. ACIP's guidance is not binding, though CDC almost always follows it and provides recommendations to the public on what is to be included in the United States adult and childhood immunization schedules. Neither the Secretary of HHS nor the CDC director can unilaterally ban vaccines. But they can alter the CDC's messaging, fire and hire ACIP committee members and revise vaccination scheduling. Moreover, the Secretary of HHS together with heads of agencies under his oversight can pursue changes in guidance that restructure regulatory pathways for vaccine development and revise recommendations to the public on who should get vaccinated. In a major policy shift last month, Food and Drug Administration officials proposed requiring new clinical trial research with respect to the effectiveness of COVID-19 vaccines in healthy people under 65, including pregnant women, before issuing an updated approval for a broader population. And we observed a preview of the new FDA approach when the agency made an unusual decision in May to limit the approval of the nation's only non-mRNA coronavirus vaccine, Novavax's nuvaxovid, for use only in adults 65 and older or those 12 to 64 who have at least one health problem that puts them at increased risk from COVID-19. And on May 31st, Moderna won approval for its latest COVID-19 vaccine with a similar set of limits. To be indicated for a broader population, the FDA plans to require that vaccine makers conduct booster trials to demonstrate effectiveness in people under 65 or without certain risks. These trials could take a year to complete, according to a STAT report. As such, it's not something that can be accomplished prior to the autumn, even if Novavax, Pfizer, or Moderna, wished to pursue this pathway. Changes are also occurring at CDC in terms of its messaging on vaccines. While all the standard childhood and adult vaccines are still on the website, the messaging in some instances incorporates more of an 'informed consent' approach than a recommendation. Informed consent is the principle that people should be notified of all the risks, as well as benefits, of any medical intervention they receive or any therapeutic they are prescribed. All of the changes we're seeing shouldn't come as a surprise. Kennedy's vaccine-skeptic views are well-known. And while he told the podcaster Lex Fridman in 2023 that some vaccines 'are probably averting more problems than they're causing,' he also maintained that 'there's no vaccine that is, you know, safe and effective.' In March, he commissioned a large-scale study to investigate debunked theories that link autism to the measles, mumps and rubella vaccine. And, amid an outbreak of measles this year that started in Texas and spread to surrounding states and cost the lives of three people, Kennedy appeared at times to downplay its severity. Kennedy has also been outspoken about the existing organizational framework within his department, in which he says that with respect to vaccines there are conflicts of interest. In announcing today's purge of the entire ACIP committee, Kennedy cited the pharmaceutical industry's close relationship with government agencies and ACIP that advises them. But it's unclear what Kennedy means when current ACIP members include academics, a chief medical officer of a community health center, a state public health higher-up and the owner of a family medicine practice. Kennedy defends himself as merely wanting placebo-controlled trials prior to licensure and no more strict vaccine mandates. However, the vaccines he criticizes are typically subject to such clinical trials. Furthermore, arguably the mandates Kennedy opposes, which have been in place since the 1960s, have helped to contribute to a dramatic decline in childhood infectious diseases. From smallpox inoculations—which began in the late 18th century and ended when the disease was eradicated in the 1970s—to mumps, rubella, tetanus, diphtheria, polio and measles immunizations, vaccinations have saved millions of lives and prevented crippling and life-threatening illnesses from occurring. To illustrate, mass vaccination programs with single or combination—measles, mumps and rubella—shots began in the 1960s and quickly suppressed the spread of measles in most developed countries. The measles vaccine is 'sterilizing,' which means it not only prevents illness, but also transmission. The American public is already increasingly vaccine-hesitant around standard childhood immunizations. This is likely to lead to more outbreaks and preventable severe illness and death. Should Kennedy appoint like-minded vaccine skeptics to the ACIP committee, that could undermine the public's trust in vaccines even further.

RFK Jr scraps vaccine committee members in effort to restore 'public trust'
RFK Jr scraps vaccine committee members in effort to restore 'public trust'

Fox News

time9 hours ago

  • Fox News

RFK Jr scraps vaccine committee members in effort to restore 'public trust'

The Department of Health and Human Services dismissed all the members of the Advisory Committee on Immunization Practices (ACIP) on Monday. The committee's job was to decide and "make recommendations" related to the necessity and use of vaccines, according to an HHS news release. All the current members of the committee were brought in under the Biden administration, and 13 of them were put on the committee last year. HHS said it would take until 2028 for most of the members to be replaced if they served their full term. Public debate about vaccines, especially whether government or workplaces should mandate them, escalated during the COVID-19 pandemic. Much of the criticism and skepticism fell on the Centers for Disease Control and Prevention, which ACIP advises. "Today we are prioritizing the restoration of public trust above any specific pro- or anti-vaccine agenda," Secretary Robert F. Kennedy said in a statement on Monday. "The public must know that unbiased science—evaluated through a transparent process and insulated from conflicts of interest—guides the recommendations of our health agencies." The HHS release noted that the next meeting for the committee will be June 25-27 in Atlanta, and the committee will have new people that are "currently under consideration." "A clean sweep is necessary to reestablish public confidence in vaccine science," Kennedy continued. "ACIP's new members will prioritize public health and evidence-based medicine. The Committee will no longer function as a rubber stamp for industry profit-taking agendas. The entire world once looked to American health regulators for guidance, inspiration, scientific impartiality, and unimpeachable integrity. Public trust has eroded. Only through radical transparency and gold standard science, will we earn it back." HHS cited an executive order from President Donald Trump saying that changes were needed in how the federal government plays a role in science and health. "Unfortunately, the Federal Government has contributed to this loss of trust. In several notable cases, executive departments and agencies (agencies) have used or promoted scientific information in a highly misleading manner," the order stated. "For example, under the prior Administration, the Centers for Disease Control and Prevention issued COVID-19 guidance on reopening schools that incorporated edits by the American Federation of Teachers and was understood to discourage in-person learning," the order, signed on May 23, continued. "This guidance's restrictive and burdensome reopening conditions led many schools to remain at least partially closed, resulting in substantial negative effects on educational outcomes — even though the best available scientific evidence showed that children were unlikely to transmit or suffer serious illness or death from the virus, and that opening schools with reasonable mitigation measures would have only minor effects on transmission," it added. Kennedy was confirmed by the Senate to lead the department in February after Trump nominated him.

Kennedy Dismisses Entire US CDC Vaccine Panel, Replacing All 17 Members
Kennedy Dismisses Entire US CDC Vaccine Panel, Replacing All 17 Members

Medscape

time10 hours ago

  • Medscape

Kennedy Dismisses Entire US CDC Vaccine Panel, Replacing All 17 Members

WASHINGTON (Reuters) -Health Secretary Robert F. Kennedy Jr. has fired all members sitting on a U.S. Centers for Disease Control and Prevention panel of vaccine experts and is reconstituting the committee, his department said on Monday. Kennedy removed all 17 members of the Advisory Committee on Immunization Practices, the Department of Health and Human Services said in a statement, and is in the process of considering new members to replace them. The ACIP panel is tasked with recommending which vaccines get placed on the CDC immunization schedule and who should get them, which helps determine insurance coverage. "Today we are prioritizing the restoration of public trust above any specific pro- or anti-vaccine agenda," Kennedy said. "The public must know that unbiased science — evaluated through a transparent process and insulated from conflicts of interest — guides the recommendations of our health agencies." All 17 sitting ACIP members were appointed under former President Joe Biden's administration, including 13 in 2024, HHS said. Not removing them would have prevented President Donald Trump's administration from choosing a majority of the committee until 2028. "That's a tragedy," former Food and Drug Administration Chief Scientist Jesse Goodman said of the firings. "This is a highly professional group of scientists and physicians and others... It's the kind of political meddling that will reduce confidence rather than increase confidence." Kennedy, who for many years has questioned the safety and efficacy of vaccines, making claims contrary to scientific evidence, said the change was necessary because the committee is rife with conflicts of interest and most members receive funding from drugmakers. But ACIP members are required to declare any potential or perceived conflicts of interest that arise in the course of ACIP tenure and any relevant business interests, positions of authority or other connections with organizations relevant to the work of the ACIP. "Our worst fears have been realized," said one expert with close ties to the committee, adding that the vetting of ACIP members "is very, very rigorous." Kennedy and HHS provided no specific evidence of industry conflicts of interest among departing ACIP members. The CDC's web page for conflicts of interest, last updated in March, showed that one current member had recused herself from votes on a handful of vaccines because she had worked on clinical trials for their manufacturers. ACIP will convene its next meeting June 25-27 at CDC headquarters in Atlanta, the department said. The change was first announced in an editorial written by Kennedy for the Wall Street Journal. At least one ACIP member who spoke on the condition of anonymity learned that they were being retired from the committee from the editorial and they believe none of the members had been notified by the CDC. ACIP members were required to disclose everything as part of the application process, including investments and all sources of income, the member said. Once the FDA approves vaccines for sale to the public, the ACIP role is to review data in a public meeting and vote on vaccine recommendations, which are then sent to the CDC director to sign off. The Affordable Care Act generally requires insurers to cover vaccines that are listed on the CDC vaccine schedule. (Reporting by Ahmed Aboulenein in Washington, Michael Erman in New York, and Julie Steenhuysen in Chicago; Additional reporting by Puyaan Singh in Bengaluru; Editing by Lisa Shumaker and Bill Berkrot)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store